We are live on ! Find out more
LGND icon

Ligand Pharmaceuticals
LGND

192 hedge funds and large institutions have $1.3B invested in Ligand Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 85 increasing their positions, 61 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

39% more repeat investments, than reductions

Existing positions increased: 85 | Existing positions reduced: 61

36% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 22

4% more funds holding

Funds holding: 184 → 192 (+8)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

8% less capital invested

Capital invested by funds: $1.4B → $1.3B (-$106M)

40% less call options, than puts

Call options by funds: $8.25M | Put options by funds: $13.8M

Holders
192
Holders Change
+8
Holders Change %
+4.35%
% of All Funds
5.52%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.17%
New
30
Increased
85
Reduced
61
Closed
22
Calls
$8.25M
Puts
$13.8M
Net Calls
-$5.6M
Net Calls Change
-$8.02M

Top Buyers

Rank Fund Capital Flow
1
CCA
Conestoga Capital Advisors
Pennsylvania
+$15.9M
2
RIM
RS Investment Management
California
+$11M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$9.79M
4
NAM
Nichols Asset Management
Massachusetts
+$8.48M
5
Goldman Sachs
Goldman Sachs
New York
+$4.84M

Top Sellers

Rank Fund Capital Flow
1
GGHC
Gilder Gagnon Howe & Co
New York
-$15.7M
2
BI
BVF Inc
California
-$13.2M
3
NCGI
Next Century Growth Investors
Minnesota
-$10M
4
CM
Castleark Management
Illinois
-$8.81M
5
Northern Trust
Northern Trust
Illinois
-$7.67M
Name Holding Trade Value Shares
Change 		Change in
Stake
BIM
51
BlackRock Investment Management
Delaware
$4.24M +$489K +12,047 +12%
GC
52
Guggenheim Capital
Illinois
$4.04M -$685K -16,877 -14%
New York State Common Retirement Fund
53
New York State Common Retirement Fund
New York
$3.85M +$1.02M +25,015 +34%
Manulife (Manufacturers Life Insurance)
54
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$3.78M +$3.06M +75,488 +347%
Macquarie Group
55
Macquarie Group
Australia
$3.74M – – –
Millennium Management
56
Millennium Management
New York
$3.46M +$1.18M +29,078 +48%
GAM
57
Gotham Asset Management
New York
$3.46M +$3.61M +88,954 New
California Public Employees Retirement System
58
California Public Employees Retirement System
California
$3.41M +$460K +11,345 +15%
IHM
59
Iguana Healthcare Management
New York
$3.12M – – –
IAM
60
Impax Asset Management
New Hampshire
$2.88M +$3.01M +74,102 New
Public Sector Pension Investment Board (PSP Investments)
61
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$2.84M +$257K +6,327 +9%
SCM
62
Suffolk Capital Management
New York
$2.7M +$1.03M +25,327 +57%
RPAM
63
Rhenman & Partners Asset Management
Sweden
$2.62M +$158K +3,900 +6%
AllianceBernstein
64
AllianceBernstein
Tennessee
$2.48M -$6.82K -168 -0.3%
Renaissance Technologies
65
Renaissance Technologies
New York
$2.4M +$2.51M +61,866 New
California State Teachers Retirement System (CalSTRS)
66
California State Teachers Retirement System (CalSTRS)
California
$2.36M +$358K +8,816 +17%
WC
67
Woodstock Corp
Massachusetts
$2.33M +$732K +18,050 +43%
Fisher Asset Management
68
Fisher Asset Management
Washington
$2.3M +$2.4M +59,164 New
BIM
69
Bogle Investment Management
Massachusetts
$2.3M -$4.54M -111,936 -65%
ARTA
70
A.R.T. Advisors
New York
$2.29M +$2.39M +59,000 New
First Trust Advisors
71
First Trust Advisors
Illinois
$2.28M -$134K -3,312 -5%
Two Sigma Investments
72
Two Sigma Investments
New York
$1.9M +$451K +11,107 +29%
CAM
73
CG Asset Management
New York
$1.74M -$447K -11,012 -20%
PA
74
Perceptive Advisors
New York
$1.73M +$1.81M +44,632 New
Susquehanna International Group
75
Susquehanna International Group
Pennsylvania
$1.61M +$1.03M +25,295 +156%
1 2
3
4 5

LGND Hedge Fund Activity: Q2 2014 in Review

192 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Ligand Pharmaceuticals (LGND) for Q2 2014, worth a combined $1.3B — down 7.6% from $1.4B a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new LGND positions and 22 closed out — a net gain of 8 holders — while 85 added to existing stakes and 61 trimmed.

The largest buyer was Conestoga Capital Advisors, opening a new position worth an estimated $15.9M. The largest seller was Gilder Gagnon Howe & Co, cutting an estimated $15.7M.

  • 192 institutional investors held Ligand Pharmaceuticals (LGND) as of Q2 2014, up from 184 in Q1 2014.
  • Funds reported $1.3B of Ligand Pharmaceuticals stock for Q2 2014, down 7.6% quarter-over-quarter.
  • 30 funds opened new Ligand Pharmaceuticals positions in Q2 2014 and 22 closed out, a net change of +8 holders.
  • The largest Ligand Pharmaceuticals buyer in Q2 2014 was Conestoga Capital Advisors, an estimated $15.9M added.
  • The largest Ligand Pharmaceuticals seller in Q2 2014 was Gilder Gagnon Howe & Co, an estimated $15.7M sold.

Based on aggregated 13F filings for Q2 2014.